Thrombolytic Therapy in the Elderly
- 1 April 1996
- journal article
- research article
- Published by Springer Nature in Drugs & Aging
- Vol. 8 (4) , 237-244
- https://doi.org/10.2165/00002512-199608040-00002
Abstract
Elderly patients have the highest absolute risk of death following an acute myocardial infarction (MI); 16.1% for those aged between 65 and 74 years, and 25.3% for those older than 75 years....Keywords
This publication has 45 references indexed in Scilit:
- Cost Effectiveness of Tissue Plasminogen ActivatorNew England Journal of Medicine, 1995
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Thrombolytic therapy for acute myocardial infarction in a 110-year-old manThe American Journal of Cardiology, 1993
- Six-year survival after coronary thrombolysis and early revascularization for acute myocardial infarctionThe American Journal of Cardiology, 1992
- Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarctionThe American Journal of Cardiology, 1991
- Guidelines for the early management of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1990
- A cost-effectiveness model for coronary thrombolysis/reperfusion therapyJournal of the American College of Cardiology, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- A NEW CORONARY PROGNOSTIC INDEXThe Lancet, 1969